| Website | exosomedx.com |
| Category | BioTech |
| Phone | 646-792-6192 |
| Employees | |
| Founded | 2008 |
| TOTAL | $20M |
| VENTURE FUNDING TOTAL | $20M |
| Series A, 5/10 NGN Capital Forbion Capital Partners | $20M |
Exosome Diagnostics, Inc. focuses on the development and commercialization of blood-based cancer molecular diagnostics for patient stratification and disease monitoring. Its minimally invasive molecular diagnostics enable to extract exosomes, which are lipid-covered microvesicles shed by solid tumors into bodily fluids, such as blood and urine of cancer patients, and detect key genes and gene mutations associated with various cancers. The company was founded in 2008 and is based in New York, New York.
